Department of Cell Biology and Physiology, University of New Mexico-Health Sciences Center, Albuquerque, NM, USA.
J Neurochem. 2012 May;121(3):486-94. doi: 10.1111/j.1471-4159.2012.07699.x. Epub 2012 Mar 14.
We recently reported that the proteasomal peptidase activities are altered in the cerebellum of mice with myelin oligodendrocyte glycoprotein (MOG) peptide-induced experimental autoimmune encephalomyelitis (EAE). To determine whether these fluctuations are caused by proteasome activation/inactivation and/or changes in the levels of individual β subunits, we characterized the proteasome subunit composition by western blotting. The results show that the rise in proteasomal peptidase activity in acute EAE correlates with an augmented expression of inducible β subunits whereas the decline in activity in chronic EAE correlates with a reduction in the amount of standard β subunits. Using pure standard (s) and immuno (i) 20S particles for calibration, we determined that the changes in the levels of catalytic subunits account for all of the fluctuations in peptidase activities in EAE. The i-20S and s-20S proteasome were found to degrade carbonylated β-actin with similar efficiency, suggesting that the amount of protein carbonyls in EAE may be controlled by the activity of both core particles. We also found an increase in proteasome activator 11S regulatory particle and a decrease in inhibitor proteasome inhibitor with molecular mass of 31 kDa levels in acute EAE, reflecting a response to inflammation. Elevated levels of 19S regulatory particle and 11S regulatory particle in chronic EAE, however, may occur in response to diminished proteasomal activity in this phase. These findings are central towards understanding the altered proteasomal physiology in inflammatory demyelinating disorders.
我们最近报道称,髓鞘少突胶质糖蛋白(MOG)肽诱导的实验性自身免疫性脑脊髓炎(EAE)小鼠小脑的蛋白酶体肽酶活性发生改变。为了确定这些波动是否是由蛋白酶体激活/失活和/或个别β亚基水平的变化引起的,我们通过 Western blot 对蛋白酶体亚基组成进行了表征。结果表明,急性 EAE 中蛋白酶体肽酶活性的升高与诱导型β亚基的表达增强相关,而慢性 EAE 中活性的下降与标准β亚基数量的减少相关。使用纯标准(s)和免疫(i)20S 颗粒进行校准,我们确定催化亚基水平的变化解释了 EAE 中肽酶活性的所有波动。发现 i-20S 和 s-20S 蛋白酶体降解羰基化的β-肌动蛋白的效率相似,这表明 EAE 中的蛋白质羰基含量可能受到两个核心颗粒活性的控制。我们还发现急性 EAE 中蛋白酶体激活物 11S 调节颗粒增加,分子量为 31 kDa 的抑制剂蛋白酶体抑制剂减少,反映了对炎症的反应。然而,慢性 EAE 中 19S 调节颗粒和 11S 调节颗粒水平的升高可能是由于该阶段蛋白酶体活性降低所致。这些发现对于理解炎症性脱髓鞘疾病中改变的蛋白酶体生理学至关重要。